Medicare Enrolled
Dr. Miteswar Purewal, MD
Pain Medicine · Havertown, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Purewal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Purewal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Purewal
Dr. Miteswar Purewal is a pain medicine specialist in Havertown, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Purewal performed 3,289 Medicare services across 1,510 unique beneficiaries.
Between the years covered by Open Payments, Dr. Purewal received a total of $19,457 from 36 pharmaceutical and/or device companies across 508 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Purewal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 11% volume in PA
$19,457 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,289
Medicare services
Top 11% in PA for pain medicine
1,510
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~164 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
758 | $103 | $601 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
721 | $71 | $420 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
510 | $0 | $1 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
367 | $59 | $280 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
133 | $41 | $230 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
128 | $192 | $890 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
124 | $33 | $180 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
107 | $42 | $240 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
95 | $149 | $700 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
89 | $130 | $780 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
61 | $1 | $5 |
| Spinal neurostimulator electrode insertion A procedure to place an electrode array into the spine through the skin. The electrode is used to deliver electrical stimulation to the nervous system. |
53 | $256 | $1,940 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
42 | $63 | $360 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
27 | $218 | $1,242 |
| Behavioral health care management, 20+ minutes This service involves clinical staff time directed by a healthcare professional to manage behavioral health conditions. It requires at least 20 minutes of dedicated clinical staff time. |
27 | $36 | $200 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
17 | $229 | $1,260 |
| Minimally invasive spine decompression, lower spine A minimally invasive procedure to remove bone from the lower spine to relieve pressure on nerve tissue, guided by imaging and accessed through the skin. |
15 | $796 | $6,210 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
15 | $165 | $964 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$19,457
Total received (2018-2024)
Avg $2,780/year across 7 years
Top 6% in PA for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
508
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,453 (58.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,292 (27.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,713 (13.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,931
2023
$1,034
2022
$2,927
2021
$5,358
2020
$1,187
2019
$5,428
2018
$1,593
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$924
Nevro Corp.
$513
Curonix LLC
$322
Boston Scientific Corporation
$149
Medtronic, Inc.
$23
Top 3 companies account for 91.1% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$11,693
Vertiflex, Inc.
$2,653
Nevro Corp.
$1,625
Vertos Medical, Inc.
$631
Boston Scientific Corporation
$460
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$382
Curonix LLC
$322
Medtronic, Inc.
$290
MML US, Inc.
$184
Flexion Therapeutics, Inc.
$132
Horizon Therapeutics plc
$118
Pacira Pharmaceuticals Incorporated
$93
Novartis Pharmaceuticals Corporation
$70
ARBOR PHARMACEUTICALS, INC.
$70
Nuvectra Corporation
$65
Takeda Pharmaceuticals U.S.A., Inc.
$62
BOSTON SCIENTIFIC CORPORATION
$59
SI-BONE, Inc.
$49
Collegium Pharmaceutical, Inc.
$49
PFIZER INC.
$46
BioDelivery Sciences International, Inc.
$46
Medtronic USA, Inc.
$45
West Therapeutics Development, LLC
$37
Purdue Pharma L.P.
$30
Egalet US Inc
$26
Pernix Therapeutics Holdings, Inc.
$26
Sentynl Therapeutics, Inc.
$26
Vertical Pharmaceuticals, LLC
$23
SCILEX PHARMACEUTICALS INC.
$22
FIDIA PHARMA USA INC.
$21
Supernus Pharmaceuticals, Inc.
$19
Scilex Pharmaceuticals Inc.
$19
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$19
Daiichi Sankyo Inc.
$16
Forte Bio-Pharma LLC
$16
Horizon Pharma plc
$11
Top 3 companies account for 82.1% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · ARYMO ER · Algovita · Amitiza · BUNAVAIL · BUNAVAIL 2.1 mg 30-count box · Cinch Epiducer SCS · DUEXIS · ETERNA · EXCLAIM · Exclaim SCS Leads · Exparel · GENERAL - PAIN MANAGEMENT · Horizant · Hymovis · INFINION · INTELLIS · INTELLIS ADAPTIVESTIM · LAMITRODE · LORZONE · LYRICA · Lamitrode SCS Leads · Lazanda · Levorphanol · Levorphanol Tartrate · Morphabond ER · NT1100 NT2000iX Simplicity · Nalocet · Neuromodulation Dspsbls and Accs · OCTRODE · Octrode SCS Leads · Omnia · PENTA · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · Penta SCS Leads · Proclaim DRG IPG · Proclaim Family of SCS IPGs · Proclaim IPG · Proclaim XR IPG · Prodigy Family of SCS IPGs · Quattrode Leads SCS Leads · RAYOS · RELISTOR · RELISTOR ORAL · Radiofrequency Therapy · ReActiv8 · SCS IPGs · SCS leads · SPECTRA WAVEWRITER · SPRIX · SWIFT-LOCK · SYMPROIC · SYNCHROMEDII · Senza · Senza Spinal Cord Stimulation System · SlimTip lead DRG Lead · Spinal Cord Stimulation Accessories · Superion ISS · Superion Indirect Decompression System · Swift-Lock SCS · TROKENDI XR · VANTA ADAPTIVESTIM · WaveWriter Alpha Prime 16 · XTAMPZA · Xtampza ER · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (59%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for pain medicine in PA.
Geographic Context
Pain medicines within 10 mi
84
Per 100K population
14.6
County median income
$88,576
Nearest hospital
MAIN LINE HOSPITAL LANKENAU
2.5 mi
2.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Purewal is a clinical cardiology specialist, with above-average Medicare volume (top 11% in PA), with low-engagement industry engagement in the top 6% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Purewal experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Purewal performed 758 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Purewal receive payments from pharmaceutical companies?
Yes. Dr. Purewal received a total of $19,457 from 36 companies across 508 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Purewal's costs compare to other pain medicines in Havertown?
Dr. Purewal's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Purewal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Havertown
Browse pain medicines in Havertown ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in PA
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in PA
Which PA pain medicines receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Vertiflex, Inc. Payments to Doctors
See all physicians who received payments from Vertiflex, Inc.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology